Vitamin E treatment in patients with nonalcoholic steatohepatitis: A six-month, open-label study of sixteen patients

Current Therapeutic Research - Clinical and Experimental

Volumn 65, Issue 3, 2004, Pages 266-277

  Yakaryilmaz, Fahri ^a,b   Guliter, Sefa ^a   Ozenirler, Seren ^a   Erdem, Ozlem ^a   Akyol, Gulen ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b Turkey ^*  (Turkey)

Author keywords

antioxidant; nonalcoholic steatohepatitis; treatment; vitamin E

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; DRUG SAFETY; DRUG TOLERABILITY; ENZYME ACTIVITY; EXERCISE; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER NECROSIS; MALE; NONALCOHOLIC FATTY LIVER; PATIENT COMPLIANCE; PRIORITY JOURNAL; SIDE EFFECT;

EID: 5444243086     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(04)80077-8     Document Type: Article

References (26)

1. Diehl AM Nonalcoholic steatohepatitis Semin Liver Dis 19 1999 221 229
2. Reid AE Nonalcoholic steatohepatitis Gastroenterology 121 2001 710 723
3. Powell EE, Cooksley WG, and Hanson R The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years Hepatology 11 1990 74 80
4. Lee RG Nonalcoholic steatohepatitis: A study of 49 patients Hum Pathol 20 1989 594 598
5. [published correction appears in Ann Intern Med. 1997; 137: 658] Sheth SG, Gordon FD, and Chopra S Nonalcoholic steatohepatitis Ann Intern Med 126 1997 137 145
6. James OF, and Day CP Non-alcoholic steatohepatitis (NASH): A disease of emerging identity and importance J Hepatol 29 1998 495 501
7. Matteoni CA, Younossi ZM, and Gramlich T Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity Gastroenterology 116 1999 1413 1419
8. Caldwell SH, Oelsner DH, and Iezzoni JC Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease Hepatology 23 1999 664 669
9. Abstract Newsome PN, Morgan K, and Hayes PC Cryptogenic cirrhosis - a disappearing disorder? Hepatology 30 1999 438A
10. Struben VM, Hespenheide EE, and Caldwell SH Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds Am J Med 108 2000 9 13
11. Pessayre D, Berson A, Fromenty B, and Mansouri A Mitochondria in steatohepatitis Semin Liver Dis 21 2001 57 69
12. Mehta K, Van Thiel DH, Shah N, and Mobarhan S Nonalcoholic fatty liver disease: Pathogenesis and the role of antioxidants Nutr Rev 60 2002 289 293
13. Angulo P, and Lindor KD Treatment of non-alcoholic steatohepatitis Best Pract Res Clin Gastroenterol 16 2002 797 810
14. Laurin J, Lindor KD, and Crippin JS Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: A pilot study Hepatology 23 1996 1464 1467
15. Abstract Guma C, Viola L, and Thome M Ursodeoxycholic acid in the treatment of nonalcoholic steatohepatitis: Results of a prospective clinical controlled trial Hepatology 26 1997 387A
16. Abstract Basaranoglu M, Acbay O, and Sonsuz A A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis J Hepatol 31 1999 384A
17. Marchesini G, Brizi M, and Bianchi G Metformin in non-alcoholic steatohepatitis Lancet 358 2001 893 894
18. Neuschwander-Tetri BA, Brunt EM, and Wehmeier KR Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone Hepatology 38 2003 1008 1017
19. Abdelmalek MF, Angulo P, and Jorgenson RA Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: Results of a pilot study Am J Gastroenterol 96 2001 2711 2717
20. Abstract Gulbahar O, Karasu ZA, and Ersoz G Treatment of nonalcoholic steatohepatitis with N-acetyl cysteine Gastroenterology 118 2000 1444A
21. Lavine JE Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study J Pediatr 136 2000 734 738
22. Hasegawa T, Yoneda M, and Nakamura K Plasma transforming growth factor-β1 level and efficacy of α-tocopherol in patients with non-alcoholic steatohepatitis: A pilot study Aliment Pharmacol Ther 15 2001 1667 1672
23. Merat S, Malekzadeh R, and Sohrabi MR Probucol in the treatment of non-alcoholic steatohepatitis: A double-blind randomized controlled study J Hepatol 38 2003 414 418
24. Brunt EM, Janney CG, and Di Bisceglie AM Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions Am J Gastroenterol 94 1999 2467 2474
25. Bellentani S, Chao YC, and Ferretti I Chronic administration of ursodeoxycholic and tauroursodeoxycholic acid changes microsomal membrane lipid content and fatty acid compositions in rats Biochem Biophys Res Commun 220 1996 479 483
26. Abstract Hasegawa T, Yoneda M, and Nakamura K Long- and short-term d-alpha-tocopherol supplementation inhibits liver collagen alpha-1 gene expression Hepatology 26 1997 250A